Park Square has placed Mark Namchuk, Ph.D. as executive director of therapeutics translation at Harvard Medical School.
Park Square has placed Jeffrey Goldberg as Chief Executive Officer and Director of Immunitas Therapeutics.
Wilkes University’s Board of Trustees announced that Greg Cant, Ph.D. will be the University’s seventh president. Cant, currently serving...
Susan E. Alcock has been named University of Michigan-Dearborn's next provost and executive vice chancellor for academic affairs,...
Check out my latest playlist update on the Park Square website (or on Spotify)! Click here to follow Aaron’s Playlist on Spotify.
Park Square has placed Arun Iyengar as Chief Executive Officer of Untether AI.
While I am not a Millennial, I have reaped the rewards of the Millennial Lifestyle Subsidy and am not complaining. However, I would...
Park Square has placed Ronald Herbst as Chief Scientific Officer at Pyxis Oncology.
Over the past 12 months, Park Square Executive Search has partnered with the investors and management of Rock Solid Technologies, a...
Park Square is pleased to announce the placement of Tyler Dolezal as the Head of Lead Generation Marketing at Rock Solid Technologies....
Park Square is pleased to announce the placement of Dr. Craig Halberstadt as Chief Scientific Officer at VitroLabs. VitroLabs is a...
Park Square is pleased to announce the placement of Sobha Pisharody, Ph.D. as Chief Product Officer at Hound Labs. Hound Labs has...
Park Square is pleased to announce the placement of Alan Hawley as Chief Revenue Officer at Climacell. ClimaCell is the world's leading...
Tiaki Therapeutics has appointed Suzanne Bruhn as CEO. Bruhn, a serial biotech CEO, arrives at Tiaki shortly after the Alzheimer’s...
The Park Square team is thrilled to support Deep Genomics and their unique, AI-driven approach to discovering and developing genetic...